Article / 2012
New Technologies in Particle Design. Interview: Colin Minchom, VP, Particle Design Business Unit
Drug Development and Delivery, October 2012
Knowledge Center
Article / 2012
Supplier Qualification. A comparison of comprehensive third-party excipient GMP audit programs
Pharmaceutical Technology, October 2012
Article / 2012
A hybrid approach to reach stringent low genotoxic impurity contents in active pharmaceutical ingredients: Combining molecularly imprinted polymers and organic solvent nanofiltration for removal of 1,3-diisopropylurea
Separation and Purification Technology (2012), 86, 79-87
Article / 2012
Carcinogenic pollutants in drug manufacturing
Magyar Kemikusok Lapja (2012), 67(2), 34-37
Article / 2012
Design of experiments as a tool for LC-MS/MS method development for the trace analysis of the potentially genotoxic 4-dimethylaminopyridine impurity in glucocorticoids
Journal of Pharmaceutical and Biomedical Analysis (2012), 70, 251-258
Article / 2012
Design, preparation and characterization of novel molecularly imprinted polymers for removal of potentially genotoxic 1,3-diisopropylurea from API solutions
Separation and Purification Technology (2012), 86, 190-198